Saturday 17 October 2026
Export GCTK’s income statement to Excel — free account
GlucoTrack, Inc.
GCTK Healthcare Medical Instruments & Supplies
In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.
0.73
0.10
−12.05%
Follow GCTK
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
4,068.29% | 381.20% | (527.20%) | (620.63%) | |
| (567.22%) | (281.60%) | (241.82%) | (272.48%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(875.52%) | (639.45%) | 2,618.45% | 1,054.70% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(247.98) | (370.43) | (149.58) | (48.55) | |
Free Cash Flow |
(14.88) | (15.34) | (16.35) | (16.22) | |
Capital Expenditures |
(0.08) | (0.10) | — | — | |
| Other line items | |||||
Cash ROIC |
(107.21%) | (112.57%) | (246.22%) | (1,226.08%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.57 | 0.79 | 0.97 | 1.02 | |
Depreciation/Fixed assets |
(1.75) | 1.62 | 3.30 | 5.69 | |
Capex/Depreciation |
0.30 | (0.43) | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(246.72) | (368.12) | (149.58) | (48.55) | |
Capex per Share |
(1.27) | (2.32) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates